The effect of pumpkin and probiotic yogurt consumption separately or/and simultaneously on type II diabetes

Journal of Isfahan Medical School

Volumn 32, Issue 283, 2014, Pages 580-589

  Bayat, Azadeh ^a   Heydaribeni, Motahar ^a   Feizi, Awat ^b   Iraj, Bijan ^a,c   Ghiasvand, Reza ^a   Askari, Gholamreza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glycemic response; Inflammatory marker; Lipid profile; Probiotic yogurt; Pumpkin; Type II diabetes

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROBIOTIC AGENT; TRIACYLGLYCEROL; YOGHURT;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SQUASH; SYSTOLIC BLOOD PRESSURE;

EID: 84908252146     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kiencke S, Handschin R, von DR, Muser J, Brunner-Larocca HP, Schumann J, et al. Preclinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail 2010; 12(9): 951-7.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87(1): 4-14.
3. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non- Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 2009; 9: 167.
4. Lutale J, Thordarson H, Sanyiwa A, Mafwiri M, Vetvik K, Krohn J. Diabetic retinopathy prevalence and its association with microalbuminuria and other risk factors in patients with type 1 and type 2 diabetes in Dar es Salaam, Tanzania. JOECSA. 2013;15(1): 3-10.
5. Suksomboon N, Poolsup N, Boonkaew S, Suthisisang CC. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. J Ethnopharmacol 2011; 137(3): 1328-33.
6. Rao MU, Sreenivasulu M, Chengaiah B, Reddy KJ, Chetty CM. Herbal medicines for diabetes mellitus: a review. Int J PharmTech Res 2010; 2(3): 1883-92.
7. Quanhong L, Caili F, Yukui R, Guanghui H, Tongyi C. Effects of protein-bound polysaccharide isolated from pumpkin on insulin in diabetic rats. Plant Foods Hum Nutr 2005; 60(1): 13-6.
8. Asemi Z, Zare Z, Shakeri H, Sabihi SS, Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs- CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013; 63(1-2): 1-9.
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499-502.
10. Kadish AH, Litle RL, Sternberg JC. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clinical Chemistry 1968; 14(2): 116-31.
11. Mazloom Z, Yousefinejad A, Dabbaghmanesh MH. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial. Iran J Med Sci 2013; 38(1): 38-43.
12. Ataei-Jafari A, Tahbaz F, Alavi-Majd H, Joodaki H. Comparison of the effect of a probiotic yogurt and ordinary yogurt on serum cholesterol levels in subjects with mild to moderate hypercholesterolemia. Iran J Diabetes Lipid Disord 2005; 4(3): 43-8. [In Persian].
13. Moroti C, Souza Magri LF, de Rezende CM, Cavallini DC, Sivieri K. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis 2012; 11: 29.
14. Diaz-Flores M, Angeles-Mejia S, Baiza-Gutman LA, Medina-Navarro R, Hernandez-Saavedra D, Ortega-Camarillo C, et al. Effect of an aqueous extract of Cucurbita ficifolia Bouche on the glutathione redox cycle in mice with STZinduced diabetes. J Ethnopharmacol 2012; 144(1): 101-8.
15. Kazemi S, Asgari S, Moshtaghian SJ, Rafieian M, Mahzouni P. Preventive effect of pumpkin (Cucurbita pepo L.) on diabetic index and histopathology of pancreas in alloxan-induced diabetes in rats. J Isfahan Med Sch 2010; 28(117): 1108-17. [In Persian].
16. Yoshinari O, Sato H, Igarashi K. Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto- Kakizaki rats. Biosci Biotechnol Biochem 2009; 73(5): 1033-41.
17. Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009; 10(9): 3755-75.
18. Aggarwal J, Swami G, Kumar M. Probiotics and their Effects on Metabolic Diseases: An Update. J Clin Diagn Res 2013; 7(1): 173-7.
19. Acosta-Patino JL, Jimenez-Balderas E, Juarez- Oropeza MA, Diaz-Zagoya JC. Hypoglycemic action of Cucurbita ficifolia on Type 2 diabetic patients with moderately high blood glucose levels. J Ethnopharmacol 2001; 77(1): 99-101.
20. Alarcon-Aguilar FJ, Hernandez-Galicia E, Campos-Sepulveda AE, Xolalpa-Molina S, Rivas-Vilchis JF, Vazquez-Carrillo LI, et al. Evaluation of the hypoglycemic effect of Cucurbita ficifolia Bouche (Cucurbitaceae) in different experimental models. J Ethnopharmacol 2002; 82(2-3): 185-9.
21. Kazemi S, Asgari S, Moshtaghian SJ, Rafieian M, Shamsi F, Shklabady R. Pumpkin preventive effect on serum lipid levels in alloxan-induced diabetic mice. J Jahrom Univ Med Sci 2011; 9 (Special): 19-25.
22. Jiang Z, Du Q. Glucose-lowering activity of novel tetrasaccharide glyceroglycolipids from the fruits of Cucurbita moschata. Bioorg Med Chem Lett 2011; 21(3): 1001-3.
23. Xia T, Wang Q. Hypoglycaemic role of Cucurbita ficifolia (Cucurbitaceae) fruit extract in streptozotocin-induced diabetic rats. J Sci Food Agric 2007; 87(9): 1753-7.
24. Yadav M, Jain S, Tomar R, Prasad GB, Yadav H. Medicinal and biological potential of pumpkin: an updated review. Nutr Res Rev 2010; 23(2): 184-90.
25. Hadisaputro S, Djokomoeljanto RR, Judiono, Soesatyo MH. The effects of oral plain kefir supplementation on proinflammatory cytokine properties of the hyperglycemia Wistar rats induced by streptozotocin. Acta Med Indones 2012; 44(2): 100-4.
26. Jeppsson B, Mangell P, Thorlacius H. Use of probiotics as prophylaxis for postoperative infections. Nutrients 2011; 3(5): 604-12.
27. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002; 50(Suppl 3): III54-III59.
28. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000; 54(4): 288-97.
29. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005; 24(4): 257-65.
30. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993; 19(1): 59-66.